The Bay Area scientific community is invited to hear experts talk about advances in cancer imaging at a symposium at the UCSF Mission Bay campus on Saturday, Oct. 14.
The symposium is scheduled from 8:45 a.m. to 6:30 p.m. in Byers Auditorium in Genentech Hall, 600 16th Street, San Francisco.
The symposium titled "Cancer Imaging: Promises to Keep" will feature state-of-the-art imaging for staging cancer and detecting recurrent disease. Recognizing the limitations in sensitivity and specificity of current technology, exciting, new approaches in various stages of development will be presented. These technologies will cover the spectrum from clinical trials, pre-clinical mouse models to development of new imaging agents.
|
Speakers
include:
•
Paul Alivisatos,
••UC
Berkeley
• Carolyn
Bertozzi,
••QB3
UC Berkeley
•
Allan Balmain,
••UCSF
•
Ben Franc,
••UCSF
•
Nola Hylton,
••UCSF
•
John Kurhanewicz,
••QB3 UCSF
•
Frank McCormick,
••UCSF
•
Sarah Nelson,
••QB3 UCSF
•
Alex Pines,
••QB3
UC Berkeley
•
Marc Shuman,
••QB3 UCSF
•
Steve Thorne,
••Stanford
• Nick
van Bruggen, ••Genentech,
Inc.
|
Speakers at the symposium represent leaders in basic and applied chemistry, physics and bioengineering research. Advances in these fields are expected to result in the ability to determine the potential of tumors to spread as well as provide in real time responsiveness of tumors to targeted cancer therapies.
The symposium is co-sponsored by the California Institute for Quantitative Biomedical Engineering or QB3, the UCSF Comprehensive Cancer Center, and the UCSF Department of Radiology. For the full agenda, please visit the
QB3 website.
Attendance is free for all academic faculty and staff. Please
register here.
